Thanks to Karl-Anthony Towns, The Leukemia & Lymphoma Society (LLS) will be getting a brand new Kia!
The NBA awarded the 2015-16 Kia NBA Rookie of the Year Award to Karl-Anthony Towns of the Minnesota Timberwolves on May 16 by handing him keys to a brand new Sorento CUV.
Towns received all 130 first-place votes from a panel of broadcasters and sportswriters in the U.S. and Canada. The seven-foot center set franchise rookie records in scoring, rebounding, blocked shots and field goal percentage this season, and his basketball talents are just as commendable as his generosity and compassion.
Town announced that he will be donating his brand new Kia to LLS’s Minnesota chapter in honor of Timberwolves executive and coach, Flip Saunders.
Saunders died in in October after a battle with Hodgkin lymphoma, and his two grandparents died from cancer as well. In honor of Saunders, Towns wore a pin with Saunders’ name on it during his acceptance of the award.
Any funds raised from resale or auction of the Kia will be directly used for supporting LLS’s mission.
The national “Moonshot” initiative is repeatedly making news headlines as the $1 billion effort designed to eliminate cancer has groundbreaking potential. Led by Vice President Joe Biden, the effort is focused on accelerating research and making more therapies available – and blood cancer patients have much to gain.
I recently joined an expert panel at the annual Milken Institute Global Conference, “Promise of the Cancer Moonshot,” to share The Leukemia & Lymphoma Society’s (LLS) perspective about what needs to be done to move this effort forward.
I was in good company.
Other speakers included Anna Barker, a professor and director of Arizona State University's Transformative Healthcare Networks; Michelle Bennett, director, Center for Research Strategy, National Cancer Institute; Robert Bradway, chairman and CEO, Amgen; and Isla Garraway, associate professor and director of research at the University of California, Los Angeles. The panel was moderated by Kathy Hudson, deputy director for science, outreach and policy, National Institutes of Health.
Unplanned weight gain is not usually discussed as a side effect of cancer treatment, but when it happens, a patient can experience other possible negative effects.
For cancer patients, weight gain is usually not a result of increased muscle, which can be a good thing, but of increased fatty tissue, which may lead to chronic inflammation. Excess body weight is linked to an increased risk for other serious medical conditions such as heart disease, diabetes, high blood pressure and circulation problems. Extra weight may also make it more difficult to perform usual daily activities such as grooming, shopping, cooking, and cleaning. A higher body weight may also require larger doses of medications.